Epstein Secrets

ld PROVIDER:Standard & Poor's ALLERGAN INC SR NT CV ZERO 22 11/06/2022 AMERICAN FINL GROUP INC OHIO SR 01.4861 06/02/2033 NT CV1. AMGEN INC NT ZER CV 32 AMYLIN PHARMACEUTICALS INC NT CV 2 BARNES GROUP INC CVT 144A CBRL GROUP INC EFTA01593609 03/01/2032 SR 02.5000 04/15/2011 03.7500 08/01/

/05 1 OF This Statement of Account is provided to you on behalf of CSFB(Europe)Ltd.- ("CSFB EL")for informational purposes only. Note this is not a CSFB LLC customer account statement. All language on back of statement(including on SIPC/excess SIPC coverage) is inapplicable. Positions shown on statement

0 2,000,000 125,000 1,075,000 :NEUTRAL INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor's ALLERGAN INC SR NT CV ZERO 22 AMGEN INC NT ZER CV 32 11/06/2022 03/01/2032 AMYLIN PHARMACEUTICALS INC NT CV 2 BARNES GROUP INC CVT 144A CBRL GROUP INC SR 02.5000 04/15/2011 EFTA01593661 03

/05 1 OF This Statement of Account is provided to you on behalf of CSFB(Europe)Ltd.- ("CSFB EL")for informational purposes only. Note this is not a CSFB LLC customer account statement. All language on back of statement(including on SIPC/excess SIPC coverage) is inapplicable. Positions shown on statement

M 746FY0 MARK TO MARKET MARK TO MARKET FUNDS PAID BY WIRE WIRE TO CITIBANK MARK TO MARKET MARK TO MARKET EFTA01593439 2,000,000 AMGEN INC NT ZER CV 32 03/01/2032 OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 276,532.98 7,658.00 276,532.98 179,941.42 1,584,660.00 11,000.00 66,798.77 66,

/05 1 OF This Statement of Account is provided to you on behalf of CSFB(Europe)Ltd.- ("CSFB EL")for informational purposes only. Note this is not a CSFB LLC customer account statement. All language on back of statement(including on SIPC/excess SIPC coverage) is inapplicable. Positions shown on statement